Twenty-eight studies were included in the review: 21 RCTs; one prospective controlled study; one observational study; three case series; and three before-and-after studies. PEDro scores ranged from 4 to 10. Nineteen RCTs were considered to be of excellent or good quality. Downs and Black scores ranged from 4 to 18. Anticonvulsants: Pregabalin (two RCTs) and gabapentin (three RCTs, one case series, one before-and-after study) were found to improve neuropathic pain after spinal cord injury, although one RCT found no significant between group differences when gabapentin was compared with an active control. No statistically significant difference in pain was found for levetiracetam (one RCT), valproic acid (one RCT) and lamotrigine (one RCT), although a subgroup of patients with incomplete spinal cord injury reported a significant improvement in neuropathic pain.
Authors' objectives
To assess the efficacy of pharmacological management of pain in individuals with spinal cord injury.
Searching
MEDLINE, CINAHL, EMBASE and PsycINFO were searched from 1980 to June 2009 for studies published in English; search terms were reported. References of retrieved articles were screened.
Study selection
Any study in which the pharmacological intervention for pain management was clearly defined and at least 50% of the participants had a spinal cord injury (minimum of three participants with spinal cord injury required) was eligible for inclusion in the review. All types of pain after spinal cord injury (such as nociceptive, neuropathic and mixed) were examined. Inclusion criteria were based on the previously established spinal Cord Injury Rehabilitation Evidence (SCIRE) methodology.
Most of the included studies were randomised controlled trials (RCTs). Other designs included case series, before and after studies, a prospective controlled study and an observational study. Included studies examined anticonvulsants, antidepressants, analgesics, cannabinoids and antispastic medications for treatment of pain after spinal cord injury. Most studies included participants with neuropathic pain after spinal cord injury. Many studies did not distinguish between neuropathic and musculoskeletal pain. A variety of pain-assessment tools was used; the two most common were visual analogue scale (VAS) and McGill Pain Questionnaire. Studies were conducted in USA, Europe and Asia.
The authors did not state how the papers were selected for inclusion in the review.
Assessment of study quality
Study quality was assessed using the PEDro scoring system for RCTs or the Downs and Black tool for non-randomised studies (maximum score of 28). PEDro assessment consisted of 11 questions with a maximum score of 10; a study with a PEDro score of 5 or lower was deemed poor quality. The included studies were also categorised according to level of evidence, using a modified Sackett scale.
Two reviewers independently assessed methodological quality. Any disagreements were resolved by a blinded third reviewer.
